A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia.

about

A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia.

Item

http://www.wikidata.org/entity/Q45072417

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

A phase I study of lenalidomid ...... s with acute myeloid leukemia.

@en

A phase I study of lenalidomid ...... s with acute myeloid leukemia.

@nl

type

Item

label

A phase I study of lenalidomid ...... s with acute myeloid leukemia.

@en

A phase I study of lenalidomid ...... s with acute myeloid leukemia.

@nl

altLabel

A phase I study of lenalidomid ...... ts with acute myeloid leukemia

@en

prefLabel

A phase I study of lenalidomid ...... s with acute myeloid leukemia.

@en

A phase I study of lenalidomid ...... s with acute myeloid leukemia.

@nl

P1476

A phase I study of lenalidomid ...... ts with acute myeloid leukemia

@en

P2093

Abigail Washington

http://www.w3.org/2001/XMLSchema#string

Adam S Sperling

http://www.w3.org/2001/XMLSchema#string

Amir T Fathi

http://www.w3.org/2001/XMLSchema#string

Benjamin L Ebert

http://www.w3.org/2001/XMLSchema#string

Daniel J DeAngelo

http://www.w3.org/2001/XMLSchema#string

David Avigan

http://www.w3.org/2001/XMLSchema#string

David P Steensma

http://www.w3.org/2001/XMLSchema#string

Eyal C Attar

http://www.w3.org/2001/XMLSchema#string

Gabriela S Hobbs

http://www.w3.org/2001/XMLSchema#string

Jacalyn Rosenblatt

http://www.w3.org/2001/XMLSchema#string

P2860

Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia

Combination regimen of cladribine (2-chlorodeoxyadenosine), cytarabine and G-CSF (CLAG) as induction therapy for patients with relapsed or refractory acute myeloid leukemia.

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion.

A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia.

Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I Trial

Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995)

Treatment of relapsed and refractory acute myelogenous leukemia.

Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse.

Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS.

Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS.

P304

254-261

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJH.24968

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dina Stroopinsky

Andrew M Brunner

P577

2017-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29119643

http://www.w3.org/2001/XMLSchema#string

P932

6290473

http://www.w3.org/2001/XMLSchema#string